Private Equity
While early and late stage VC-backed businesses are poised to weather this period of uncertainty, companies at the Series B and C stages may be left behind.
2 min read · 02 April 2020
It has become an important source of capital for start-ups in recent years. But corporate investing will likely pull back substantially during the downturn.
2 min read · 02 April 2020
Firms backing industrials companies will modify investment strategies in the post coronavirus world, with those who can likely to increase US operations and downsize overseas operations in the supply chain.
5 min read · 02 April 2020
How the CARES Act may affect PE-backed healthcare companies and New Mountain Capital's sale of Equian wins Deal of the Year.
4 min read · 02 April 2020
New Mountain Capital's sale of Equian is the Deal of the Year and "tourist" LP co-investors could get exposed in the pandemic downturn.
4 min read · 02 April 2020
Foreign PE firms looking to acquire healthcare-related companies in Europe can expect another three months of FDI review added to the deal process.
3 min read · 02 April 2020
The lesson from FFL’s investment in Crisis Prevention Institute is to not be afraid to take risks with a company that is already performing well.
4 min read · 02 April 2020
Telemedicine valuations will rise following substantial adoption growth, and investors see a compelling thesis around these services even after coronavirus fears abate.
4 min read · 01 April 2020
1 min read · 01 April 2020
KKR has named Hidekazu Harada as a managing director to its Tokyo-based private equity team.
1 min read · 01 April 2020
